The main purpose of the study is to get information about the safety and efficacy of
treatment with Dapsone to prevent the disability after ischemic Stroke, in patients diagnosed
with anterior territory brain infarct.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Cidat, S.A. de C.V.
Collaborator:
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez